Patent Assignment Details
NOTE:Results display only for issued patents and published applications.
For pending or abandoned applications please consult USPTO staff.
|
Reel/Frame: | 026570/0136 | |
| Pages: | 9 |
| | Recorded: | 07/11/2011 | | |
Attorney Dkt #: | PAT053194-US-PCT |
Conveyance: | ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). |
|
Total properties:
1
|
|
Patent #:
|
|
Issue Dt:
|
05/08/2012
|
Application #:
|
13140453
|
Filing Dt:
|
06/17/2011
|
Publication #:
|
|
Pub Dt:
|
10/13/2011
| | | | |
Title:
|
NEW POLYMORPHIC FORM OF 1-(4-{1-[(E)-4-CYCLOHEXYL-3-TRIFLUOROMETHYL-BENZYLOXYIMINO]-ETHYL}-2-ETHYL-BENZYL)-AZETIDINE-3-CARBOXYLIC
|
|
Assignee
|
|
|
LICHTSTRASSE 35 |
BASEL, SWITZERLAND 4056 |
|
Correspondence name and address
|
|
KAREN DEBENEDICTIS
|
|
NOVARTIS PHARMACEUTICALS CORPORATION
|
|
ONE HEALTH PLAZA, BLDG 101
|
|
EAST HANOVER, NJ 07936
|
Search Results as of:
06/25/2024 07:56 AM
If you have any comments or questions concerning the data displayed,
contact
PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified:
August 25, 2017 v.2.6
|